PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Nov 30, 2016
Insider Transaction Report
Form 4
Runge Jeffrey W.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2016-11-28−20,000→ 0 totalExercise: $2.20From: 2016-11-17Exp: 2026-05-31→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock, par value $0.0001 per share
2016-11-28$2.20/sh+20,000$44,000→ 177,700 total